Showing results (231-240 of 261) with videos related to
Sort By:
Pageof 27
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2024
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensusT Torres, N C Brembilla, R G Langley, et al.Journal of the American Academy of Dermatology|July 21, 2022
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trialAndrew Blauvelt, Richard G Langley, Jean-Philippe Lacour, et al.JAMA|August 25, 2011
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trialsCaitriona Ryan, Craig L Leonardi, James G Krueger, et al.Journal of Cutaneous Medicine and Surgery|December 29, 2023
Using Artificial Intelligence as a Melanoma Screening Tool in Self-Referred PatientsMadeleine E Crawford, Kiyana Kamali, Rachel A Dorey, et al.The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.Dermatology and Therapy|February 5, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTENDAndrew Blauvelt, H Chih-Ho Hong, Norito Katoh, et al.The British Journal of Dermatology|August 29, 2025
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of 8 clinical trialsKristian Reich, Richard G Langley, Juan Francisco Silvestre Salvador, et al.The Journal of Allergy and Clinical Immunology|January 24, 2026
Bimekizumab long-term response in psoriasis: Mechanistic insights into efficacy level and durabilityJames G Krueger, Ioana Cutcutache, Mark Lebwohl, et al.Journal of the American Academy of Dermatology|July 17, 2007
In vivo reflectance confocal microscopy imaging of melanocytic skin lesions: consensus terminology glossary and illustrative imagesAlon Scope, Cristiane Benvenuto-Andrade, Anna-Liza C Agero, et al.Archives of Dermatological Research|June 8, 2024
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registryKim A Papp, Melinda Gooderham, Charles Lynde, et al.Pageof 27